Ironwood Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-07 07:05:00 ET IRWD

Published on 05/07/2025 at 07:05, updated on 05/07/2025 at 09:05

Ironwood Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 41.14 million compared to USD 74.88 million a year ago. Net loss was USD 37.39 million compared to USD 4.16 million a year ago.

Basic loss per share from continuing operations was USD 0.23 compared to USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.23 compared to USD 0.03 a year ago.